Precision Surgery News Today

particularly in central and southern parts of england. frosty tonight, already temperatures are minus nine in scotland. there is the fog, the mist and low cloud. it will shrink and break up, sunshine coming through for many. but grey and murky in lincolnshire. some showers in north—west england and a cold day. temperatures one to that he celsius. coming into that cold air we have showers that are going but with thousands of civilian casualties, are israels western allies now changing...

Medicenna Therapeutics Corp. announced that a poster presentation and an oral summary highlighting longer term follow up results from the Phase 2b clinical trial of bizaxofusp , the Companys...

TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a...

Are cutting-edge medical scans or high-tech X-rays really safe? We will look into advanced imaging in this article to answer these important questions, as well as others, in detail.In a nutshell, advanced imaging technology has changed the face of healthcare, research, and the entire sciences. It allows us to peer inside our body with remarkable

The White House recently announced the Precision Surgery Initiative (PSI) as a "first-of-its kind Advanced Research Projects Agency for Health (ARPA-H) program to develop novel technologies"...

More than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer mortality is high largely because it tends to be...

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery.

The FDA approved the imaging agent Cytalux for use in lung cancer cases to help surgeons find and remove previously unidentified tumors.

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and...

/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing intraoperative molecular imaging agents to target and...